Key result
Macrophage and T-cell subsets drive opposing atherosclerotic pathways, highlighting novel immunotherapeutic targets.
Answers are grounded in this paper and cite their sources.
Atherosclerosis is now considered a chronic maladaptive inflammatory disease. The hallmark feature in both human and murine disease is atherosclerotic plaques. Macrophages and various T-cell lineages play a crucial role in atherosclerotic plaque establishment and disease progression. Humans and mice share many of the same processes that occur within atherogenesis. The various similarities enable considerable insight into disease mechanisms and those which contribute to cardiovascular complications. The apolipoprotein E-null and low-density lipoprotein receptor-null mice have served as the foundation for further immunological pathway manipulation to identify pro- and antiatherogenic pathways in attempt to reveal more novel therapeutic targets. In this review, we provide a translational perspective and discuss the roles of macrophages and various T-cell lineages in contrasting proatherosclerotic and atheroprotective settings.
No takes yet. Share an insight, caveat, or question.
Bartlett et al. (2019) conducted a review in Atherosclerosis. Macrophages and T-cell lineages play crucial roles in proatherosclerotic and atheroprotective pathways in human and murine atherosclerosis, offering potential novel therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: